Bondeson, J., Foxwell, B., Brennan, F., & Feldmann, M. (1999). Defining therapeutic targets by using adenovirus: Blocking NF-kappaB inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares anti-inflammatory mediators.

Bondeson, J., B. Foxwell, F. Brennan, and M. Feldmann. Defining Therapeutic Targets by Using Adenovirus: Blocking NF-kappaB Inhibits Both Inflammatory and Destructive Mechanisms in Rheumatoid Synovium but Spares Anti-inflammatory Mediators. 1999.

Bondeson, J., et al. Defining Therapeutic Targets by Using Adenovirus: Blocking NF-kappaB Inhibits Both Inflammatory and Destructive Mechanisms in Rheumatoid Synovium but Spares Anti-inflammatory Mediators. 1999.